Delivery Order SPE2DR25D2014-SPE2DR26FZ81A
- Not listed
- The Defense Logistics Agency awarded a $1,278.64 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of CAPLYTA 42 mg capsules (30-count units). AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was selected through competitive procurement with no set-aside designation. The delivery order has an ultimate completion date of July 23, 2025, with performance at the contractor's Conshohocken...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of CAPLYTA 42 mg capsules (30-unit packages) with a ceiling value of $2,971.27 under firm fixed pricing. The award, issued on November 7, 2025, with an ultimate completion date of November 10, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- The Defense Logistics Agency awarded a $7,979.16 delivery order to AmerisourceBergen Drug Corp for CAPLYTA 42 mg capsules (30-unit supply) on December 12, 2025, with an ultimate completion date of December 15, 2025. This firm fixed price contract, which carries no set-aside designation, represents a competitive award for pharmaceutical supply to support federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $2,868.18 to supply CAPLYTA 42 mg capsules (30-count units) under a firm fixed-price contract. The order was competitively awarded without set-aside designation and is scheduled for completion by December 11, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, fulfilled this order from its corporate office location, leveraging its established role as a critical pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $2,138.70 to AmerisourceBergen Drug Corp for the supply of Caplyta 21 mg capsules (30-count) on May 27, 2025, with completion expected by May 28, 2025. This non-competitive, firm fixed-price delivery order represents a pharmaceutical supply transaction under the company's broader indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,086.74 to AmerisourceBergen Drug Corp for the supply of CAPLYTA 21 MG capsules (30-count units) under a firm fixed-price contract. The delivery order, issued on February 2, 2026, with an ultimate completion date of February 3, 2026, represents a non-set-aside, competitively awarded transaction. Performance of this order will be executed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a $6,535.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of CAPLYTA 42 mg capsules (30-count units). The contract, which is not set-aside, is scheduled for completion by November 19, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of CAPLYTA 42 mg capsules (30-count packages) with a contract value of $7,397.74. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 9, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the contractor's demonstrated...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,074.72 to supply CAPLYTA 42 mg capsules (30-count units) under a firm fixed price contract, with a completion date of December 31, 2025. This non-set-aside award reflects competitive procurement of a branded pharmaceutical product for federal medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $21,502.21 to AmerisourceBergen Drug Corp for 30-count supplies of CAPLYTA 42 mg capsules, with an ultimate completion date of October 27, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with the DLA. The pharmaceutical product will be performed and delivered from the company's operations...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FZ81ADelivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,064.84 to AmerisourceBergen Drug Corp for the supply of CAPLYTA 21 mg capsules (30-count units) under a firm fixed price contract. The award was made on November 25, 2025, with an ultimate completion date of November 26, 2025, and represents a non-competitive set-aside transaction. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this delivery order from its corporate office location. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 and extends through December 2026. This comprehensive global pharmaceutical support vehicle enables the contractor to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including critical medications, vaccines, syringes, vials, and test kits across multiple therapeutic domains. Through this IDC framework, AmerisourceBergen serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.1k | 11/24/25 |